Company news
Navamedic ASA news in 2025
Navamedic ASA's news releases, calls and decks from 2025, newest first.
Navamedic ASA: Notice of extraordinary general meeting on 7 January 2026
December 12, 2025
Navamedic ASA: Appointment of CFO
December 8, 2025
Navamedic ASA: Resignation of CFO
November 28, 2025
Navamedic ASA: Double digit growth in the 3rd quarter, 2025
October 28, 2025
Navamedic ASA: Invitation to 2025 3rd quarter presentation
October 24, 2025
Navamedic ASA: Navamedic extends its business into Germany together with Evolsin Medical
October 17, 2025
Notification of major holdings
October 15, 2025
Navamedic ASA - New share capital registered
October 13, 2025
Navamedic ASA: Financial report for the 2nd quarter and first half of 2025
August 14, 2025
Navamedic ASA: National approvals of Flexilev® in OraFID® granted across all Nordic countries
August 13, 2025
Navamedic ASA: Closing of the transaction to acquire the business of dne pharma
July 15, 2025
Navamedic ASA - Minutes of Extraordinary General Meeting
July 14, 2025
Navamedic ASA: First approval of the medical device OraFID® as primary package for a pharmaceutical product
June 27, 2025
Navamedic ASA - Investor presentation regarding the acquisition of the business of dne pharma AS
June 24, 2025
Navamedic ASA expands into addiction treatment through the acquisition of the business of dne pharma and announces a partially underwritten rights issue
June 23, 2025
Navamedic ASA: Annual Report 2024
April 30, 2025
Navamedic ASA: Imdur® distribution agreement extended to 2032
April 29, 2025
Decks in 2025
- Q3 2025 Earnings Presentation
Earnings · 22 slides · Oct 28, 2025
- Q2 2025 Earnings Presentation
Earnings · 24 slides · Aug 14, 2025
- Investor Presentation (June 2025)
Investor deck · 13 slides · Jun 24, 2025
- Q1 2025 Earnings Presentation
Earnings · 20 slides · Apr 30, 2025
- Q4 2024 Earnings Presentation
Earnings · 21 slides · Feb 12, 2025